Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Orbital Diseases | 18 | 2023 | 178 | 8.000 |
Why?
|
Orbit | 26 | 2024 | 456 | 6.890 |
Why?
|
Eyelids | 16 | 2024 | 279 | 3.940 |
Why?
|
Graves Ophthalmopathy | 12 | 2024 | 135 | 3.830 |
Why?
|
Eyelid Diseases | 11 | 2024 | 155 | 3.810 |
Why?
|
Eyelid Neoplasms | 8 | 2019 | 84 | 3.260 |
Why?
|
Ophthalmologic Surgical Procedures | 13 | 2024 | 354 | 3.210 |
Why?
|
Orbital Fractures | 6 | 2020 | 108 | 2.640 |
Why?
|
Orbital Neoplasms | 9 | 2018 | 223 | 2.620 |
Why?
|
Cysts | 8 | 2022 | 684 | 2.400 |
Why?
|
Orbital Cellulitis | 4 | 2023 | 33 | 2.350 |
Why?
|
Lacrimal Apparatus | 5 | 2024 | 224 | 2.320 |
Why?
|
Blepharoptosis | 7 | 2024 | 143 | 2.210 |
Why?
|
Dacryocystitis | 4 | 2022 | 67 | 1.930 |
Why?
|
Nasolacrimal Duct | 5 | 2019 | 79 | 1.800 |
Why?
|
Lacrimal Apparatus Diseases | 6 | 2024 | 72 | 1.750 |
Why?
|
Dacryocystorhinostomy | 7 | 2024 | 78 | 1.680 |
Why?
|
Conjunctival Diseases | 4 | 2020 | 109 | 1.670 |
Why?
|
Epidermal Cyst | 3 | 2017 | 62 | 1.540 |
Why?
|
Blepharoplasty | 3 | 2023 | 59 | 1.510 |
Why?
|
Temporal Arteries | 7 | 2015 | 154 | 1.450 |
Why?
|
Ophthalmology | 7 | 2024 | 561 | 1.420 |
Why?
|
Oculomotor Muscles | 8 | 2024 | 404 | 1.410 |
Why?
|
Sinusitis | 4 | 2022 | 995 | 1.360 |
Why?
|
Enophthalmos | 5 | 2019 | 34 | 1.360 |
Why?
|
Conjunctiva | 5 | 2020 | 477 | 1.320 |
Why?
|
Eye Infections, Fungal | 3 | 2022 | 99 | 1.290 |
Why?
|
Cavernous Sinus | 2 | 2021 | 119 | 1.290 |
Why?
|
Decompression, Surgical | 7 | 2021 | 603 | 1.210 |
Why?
|
Keratins | 4 | 2017 | 498 | 1.120 |
Why?
|
Face | 5 | 2023 | 1028 | 1.110 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 2 | 2017 | 52 | 1.080 |
Why?
|
Eye Foreign Bodies | 2 | 2020 | 51 | 1.060 |
Why?
|
Lacrimal Duct Obstruction | 5 | 2024 | 53 | 1.050 |
Why?
|
Emphysema | 2 | 2019 | 234 | 1.050 |
Why?
|
Hair Diseases | 2 | 2017 | 73 | 1.050 |
Why?
|
Conjunctival Neoplasms | 2 | 2017 | 78 | 1.040 |
Why?
|
Biopsy | 18 | 2024 | 6763 | 1.000 |
Why?
|
Eye Injuries, Penetrating | 2 | 2020 | 121 | 0.960 |
Why?
|
Hematoma | 3 | 2020 | 766 | 0.910 |
Why?
|
Optic Nerve Diseases | 2 | 2022 | 343 | 0.910 |
Why?
|
Giant Cell Arteritis | 6 | 2015 | 302 | 0.900 |
Why?
|
Orbital Implants | 3 | 2021 | 20 | 0.880 |
Why?
|
Eye Diseases | 3 | 2019 | 659 | 0.860 |
Why?
|
Ectropion | 2 | 2020 | 27 | 0.840 |
Why?
|
Photography | 2 | 2016 | 533 | 0.820 |
Why?
|
Choristoma | 2 | 2016 | 206 | 0.810 |
Why?
|
Exophthalmos | 5 | 2024 | 99 | 0.770 |
Why?
|
Facial Nerve Injuries | 2 | 2013 | 64 | 0.760 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 230 | 0.750 |
Why?
|
Anophthalmos | 2 | 2021 | 23 | 0.750 |
Why?
|
Diagnosis, Differential | 18 | 2024 | 12976 | 0.740 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2021 | 14 | 0.740 |
Why?
|
Surgery, Computer-Assisted | 3 | 2024 | 993 | 0.740 |
Why?
|
Neoplasms, Basal Cell | 1 | 2021 | 30 | 0.730 |
Why?
|
Entropion | 1 | 2020 | 9 | 0.730 |
Why?
|
Keratosis, Seborrheic | 1 | 2021 | 31 | 0.730 |
Why?
|
Dermoid Cyst | 1 | 2021 | 91 | 0.720 |
Why?
|
Mucocele | 1 | 2020 | 51 | 0.700 |
Why?
|
Eyelashes | 2 | 2017 | 20 | 0.680 |
Why?
|
Tomography, X-Ray Computed | 20 | 2024 | 20659 | 0.670 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 109 | 0.670 |
Why?
|
Humans | 134 | 2024 | 765968 | 0.660 |
Why?
|
Blinking | 2 | 2020 | 135 | 0.660 |
Why?
|
Diplopia | 7 | 2024 | 217 | 0.650 |
Why?
|
Scleroderma, Localized | 2 | 2018 | 85 | 0.650 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2018 | 180 | 0.650 |
Why?
|
Skin Neoplasms | 5 | 2021 | 5849 | 0.650 |
Why?
|
Subcutaneous Emphysema | 1 | 2019 | 15 | 0.650 |
Why?
|
Limbus Corneae | 1 | 2021 | 144 | 0.630 |
Why?
|
Maxillary Fractures | 1 | 2019 | 21 | 0.630 |
Why?
|
Hypesthesia | 2 | 2019 | 106 | 0.630 |
Why?
|
Zygomatic Fractures | 1 | 2019 | 35 | 0.630 |
Why?
|
Postoperative Complications | 9 | 2021 | 15747 | 0.630 |
Why?
|
Masks | 1 | 2021 | 209 | 0.630 |
Why?
|
Injections | 1 | 2022 | 840 | 0.630 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2024 | 252 | 0.620 |
Why?
|
Trichiasis | 1 | 2018 | 5 | 0.620 |
Why?
|
Botulinum Toxins, Type A | 1 | 2022 | 238 | 0.610 |
Why?
|
Eye Injuries | 2 | 2019 | 228 | 0.600 |
Why?
|
Facial Neoplasms | 1 | 2019 | 127 | 0.590 |
Why?
|
Acrylates | 1 | 2018 | 75 | 0.590 |
Why?
|
Ophthalmoplegia | 1 | 2019 | 168 | 0.590 |
Why?
|
Granuloma, Foreign-Body | 1 | 2018 | 41 | 0.590 |
Why?
|
Frontal Bone | 1 | 2018 | 105 | 0.590 |
Why?
|
Retrospective Studies | 40 | 2024 | 81514 | 0.580 |
Why?
|
Facial Nerve | 1 | 2020 | 277 | 0.570 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2017 | 40 | 0.570 |
Why?
|
Orbital Pseudotumor | 3 | 2024 | 40 | 0.570 |
Why?
|
Carcinoma, Basal Cell | 2 | 2021 | 566 | 0.570 |
Why?
|
Facial Dermatoses | 1 | 2018 | 87 | 0.570 |
Why?
|
Doxycycline | 1 | 2019 | 349 | 0.570 |
Why?
|
Mucormycosis | 2 | 2015 | 104 | 0.560 |
Why?
|
Endoscopy | 7 | 2024 | 1841 | 0.560 |
Why?
|
Glucocorticoids | 9 | 2024 | 2132 | 0.540 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 437 | 0.540 |
Why?
|
Gelatin | 1 | 2018 | 227 | 0.540 |
Why?
|
Biometric Identification | 1 | 2016 | 6 | 0.530 |
Why?
|
Hair Follicle | 2 | 2016 | 224 | 0.530 |
Why?
|
Lymphangioma | 2 | 2014 | 60 | 0.530 |
Why?
|
Exanthema | 1 | 2021 | 502 | 0.520 |
Why?
|
Meningomyelocele | 1 | 2018 | 182 | 0.520 |
Why?
|
Aneurysm | 1 | 2019 | 337 | 0.520 |
Why?
|
Pigmentation | 1 | 2016 | 143 | 0.520 |
Why?
|
Cosmetic Techniques | 1 | 2018 | 149 | 0.510 |
Why?
|
Retinal Vein Occlusion | 1 | 2017 | 149 | 0.500 |
Why?
|
Hemostatics | 1 | 2018 | 247 | 0.500 |
Why?
|
Melanosis | 1 | 2016 | 93 | 0.490 |
Why?
|
Blindness | 1 | 2019 | 586 | 0.490 |
Why?
|
Human papillomavirus 16 | 1 | 2017 | 268 | 0.480 |
Why?
|
Rhinoplasty | 1 | 2019 | 241 | 0.480 |
Why?
|
Ophthalmic Artery | 1 | 2015 | 56 | 0.480 |
Why?
|
Corneal Diseases | 2 | 2019 | 535 | 0.470 |
Why?
|
Granuloma | 1 | 2017 | 327 | 0.470 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2019 | 328 | 0.470 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2015 | 67 | 0.460 |
Why?
|
Hyaluronic Acid | 1 | 2018 | 484 | 0.460 |
Why?
|
Chalazion | 1 | 2014 | 10 | 0.460 |
Why?
|
Elastic Tissue | 1 | 2014 | 66 | 0.460 |
Why?
|
Middle Aged | 46 | 2024 | 223009 | 0.460 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1560 | 0.460 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 243 | 0.460 |
Why?
|
Neuroma | 1 | 2016 | 137 | 0.450 |
Why?
|
Foreign Bodies | 1 | 2018 | 402 | 0.450 |
Why?
|
Sphenoid Bone | 1 | 2015 | 176 | 0.440 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2014 | 66 | 0.440 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2015 | 166 | 0.430 |
Why?
|
Abscess | 3 | 2022 | 606 | 0.430 |
Why?
|
Male | 60 | 2024 | 363698 | 0.430 |
Why?
|
Prosthesis Implantation | 2 | 2021 | 595 | 0.430 |
Why?
|
Aspergillosis | 1 | 2015 | 242 | 0.420 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2015 | 119 | 0.420 |
Why?
|
Waiting Lists | 1 | 2018 | 777 | 0.420 |
Why?
|
Ethmoid Bone | 1 | 2013 | 35 | 0.420 |
Why?
|
Nasal Bone | 1 | 2013 | 58 | 0.410 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 874 | 0.410 |
Why?
|
Eyebrows | 1 | 2013 | 38 | 0.410 |
Why?
|
Craniotomy | 2 | 2014 | 730 | 0.410 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2013 | 35 | 0.410 |
Why?
|
Carcinoma, Lobular | 1 | 2017 | 471 | 0.410 |
Why?
|
Pseudolymphoma | 1 | 2012 | 30 | 0.410 |
Why?
|
Intracranial Hypotension | 1 | 2013 | 42 | 0.410 |
Why?
|
Eye Neoplasms | 1 | 2014 | 304 | 0.400 |
Why?
|
Sella Turcica | 1 | 2013 | 117 | 0.400 |
Why?
|
Adult | 41 | 2024 | 223044 | 0.400 |
Why?
|
Hydrogels | 1 | 2018 | 728 | 0.400 |
Why?
|
Cornea | 2 | 2019 | 1316 | 0.400 |
Why?
|
Hemangioma, Cavernous | 1 | 2013 | 105 | 0.400 |
Why?
|
Respiratory Mucosa | 1 | 2016 | 438 | 0.400 |
Why?
|
Surgical Wound Infection | 1 | 2021 | 1543 | 0.390 |
Why?
|
Female | 57 | 2024 | 396112 | 0.390 |
Why?
|
Visual Field Tests | 2 | 2012 | 415 | 0.390 |
Why?
|
Skin Transplantation | 2 | 2015 | 1098 | 0.390 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2013 | 186 | 0.380 |
Why?
|
Skull Fractures | 1 | 2013 | 202 | 0.370 |
Why?
|
Surgery, Plastic | 1 | 2018 | 651 | 0.370 |
Why?
|
Aged | 34 | 2024 | 171117 | 0.350 |
Why?
|
Keratin-17 | 3 | 2016 | 26 | 0.350 |
Why?
|
Societies, Medical | 3 | 2024 | 3956 | 0.350 |
Why?
|
Hemianopsia | 1 | 2012 | 121 | 0.350 |
Why?
|
Paranasal Sinuses | 1 | 2013 | 267 | 0.350 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1927 | 0.340 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2017 | 1083 | 0.340 |
Why?
|
Boronic Acids | 1 | 2014 | 916 | 0.340 |
Why?
|
Anti-Bacterial Agents | 4 | 2023 | 7478 | 0.340 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1273 | 0.340 |
Why?
|
Light | 1 | 2016 | 1365 | 0.340 |
Why?
|
Aged, 80 and over | 19 | 2024 | 59489 | 0.330 |
Why?
|
Aphasia | 1 | 2011 | 191 | 0.330 |
Why?
|
Vision, Low | 1 | 2011 | 162 | 0.330 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 691 | 0.320 |
Why?
|
Disease Management | 1 | 2020 | 2535 | 0.320 |
Why?
|
Hair | 1 | 2012 | 508 | 0.320 |
Why?
|
Program Evaluation | 1 | 2017 | 2499 | 0.320 |
Why?
|
Magnetic Resonance Imaging | 16 | 2024 | 36532 | 0.310 |
Why?
|
Visual Acuity | 7 | 2019 | 2708 | 0.310 |
Why?
|
Skull | 1 | 2013 | 811 | 0.300 |
Why?
|
Pyrazines | 1 | 2014 | 1204 | 0.300 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1499 | 0.300 |
Why?
|
Registries | 1 | 2024 | 8297 | 0.290 |
Why?
|
Adipose Tissue | 1 | 2019 | 3312 | 0.290 |
Why?
|
Mucopolysaccharidosis II | 1 | 2007 | 26 | 0.280 |
Why?
|
Visual Fields | 2 | 2012 | 1063 | 0.280 |
Why?
|
Intraoperative Complications | 1 | 2014 | 1162 | 0.280 |
Why?
|
Lymphoma | 1 | 2016 | 1897 | 0.280 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 689 | 0.280 |
Why?
|
Neoplasm Proteins | 3 | 2016 | 3596 | 0.260 |
Why?
|
Skin | 3 | 2016 | 4489 | 0.260 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13648 | 0.250 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3211 | 0.250 |
Why?
|
Ultrasonography | 1 | 2019 | 5993 | 0.250 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2418 | 0.240 |
Why?
|
Software | 2 | 2016 | 4462 | 0.240 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1640 | 0.240 |
Why?
|
Keratin-7 | 2 | 2016 | 55 | 0.240 |
Why?
|
Skin Diseases | 1 | 2012 | 1088 | 0.230 |
Why?
|
Immunohistochemistry | 5 | 2016 | 11022 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4044 | 0.220 |
Why?
|
Nerve Regeneration | 2 | 2020 | 802 | 0.220 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 3078 | 0.210 |
Why?
|
Immunotherapy | 1 | 2019 | 4752 | 0.210 |
Why?
|
Orbit Evisceration | 1 | 2022 | 9 | 0.210 |
Why?
|
Philadelphia Chromosome | 1 | 2023 | 119 | 0.210 |
Why?
|
Syringoma | 1 | 2022 | 8 | 0.210 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11206 | 0.200 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39193 | 0.200 |
Why?
|
Staining and Labeling | 2 | 2018 | 1072 | 0.200 |
Why?
|
Tears | 1 | 2024 | 254 | 0.200 |
Why?
|
Neurology | 1 | 2010 | 785 | 0.200 |
Why?
|
Shewanella | 1 | 2022 | 12 | 0.200 |
Why?
|
Young Adult | 9 | 2024 | 59889 | 0.200 |
Why?
|
Debridement | 2 | 2015 | 495 | 0.190 |
Why?
|
Eye | 2 | 2023 | 710 | 0.190 |
Why?
|
Fundus Oculi | 2 | 2017 | 559 | 0.190 |
Why?
|
Recurrence | 2 | 2024 | 8501 | 0.180 |
Why?
|
Sweat Gland Neoplasms | 1 | 2022 | 110 | 0.180 |
Why?
|
Adolescent | 11 | 2024 | 88835 | 0.180 |
Why?
|
Rejuvenation | 1 | 2022 | 109 | 0.180 |
Why?
|
Calcinosis | 2 | 2022 | 1479 | 0.170 |
Why?
|
Papilledema | 1 | 2022 | 130 | 0.170 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5508 | 0.170 |
Why?
|
Folliculitis | 1 | 2019 | 25 | 0.170 |
Why?
|
Breast Neoplasms | 2 | 2017 | 21056 | 0.170 |
Why?
|
Strabismus | 1 | 2024 | 320 | 0.160 |
Why?
|
Optic Neuritis | 1 | 2022 | 172 | 0.160 |
Why?
|
Ophthalmic Nerve | 1 | 2019 | 43 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8923 | 0.160 |
Why?
|
Adrenal Cortex Hormones | 2 | 2023 | 1880 | 0.160 |
Why?
|
Evidence-Based Medicine | 2 | 2024 | 3685 | 0.160 |
Why?
|
Oculomotor Nerve | 1 | 2019 | 72 | 0.150 |
Why?
|
Scalp | 1 | 2021 | 388 | 0.150 |
Why?
|
Neurofibroma | 1 | 2018 | 94 | 0.140 |
Why?
|
Steroids | 1 | 2023 | 933 | 0.140 |
Why?
|
Injections, Intralesional | 2 | 2015 | 281 | 0.140 |
Why?
|
Nerve Transfer | 1 | 2019 | 138 | 0.140 |
Why?
|
Fluorescein Angiography | 2 | 2017 | 1085 | 0.140 |
Why?
|
Internship and Residency | 1 | 2017 | 5946 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8529 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20124 | 0.140 |
Why?
|
Tick Infestations | 1 | 2016 | 9 | 0.130 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5197 | 0.130 |
Why?
|
Eye Infections, Parasitic | 1 | 2016 | 27 | 0.130 |
Why?
|
Orbital Myositis | 1 | 2016 | 23 | 0.130 |
Why?
|
Drainage | 1 | 2022 | 1179 | 0.130 |
Why?
|
Keratin-18 | 1 | 2016 | 37 | 0.130 |
Why?
|
Myofibromatosis | 1 | 2016 | 28 | 0.130 |
Why?
|
Muscles | 1 | 2021 | 1578 | 0.130 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2015 | 23 | 0.130 |
Why?
|
Myofibroma | 1 | 2016 | 45 | 0.130 |
Why?
|
Curettage | 1 | 2015 | 74 | 0.120 |
Why?
|
Ethmoid Sinus | 1 | 2015 | 58 | 0.120 |
Why?
|
Vision Disorders | 1 | 2022 | 1087 | 0.120 |
Why?
|
United States | 7 | 2024 | 72903 | 0.120 |
Why?
|
Mucorales | 1 | 2015 | 35 | 0.120 |
Why?
|
Triamcinolone | 1 | 2015 | 68 | 0.120 |
Why?
|
Head | 1 | 2021 | 925 | 0.120 |
Why?
|
Aspergillus | 1 | 2015 | 93 | 0.120 |
Why?
|
Nose Diseases | 1 | 2015 | 79 | 0.120 |
Why?
|
Keratin-14 | 1 | 2014 | 57 | 0.120 |
Why?
|
Lasers, Semiconductor | 1 | 2015 | 44 | 0.120 |
Why?
|
Sphenoid Sinus | 1 | 2015 | 100 | 0.120 |
Why?
|
Wounds, Nonpenetrating | 2 | 2013 | 807 | 0.120 |
Why?
|
Headache | 1 | 2022 | 1259 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 540 | 0.110 |
Why?
|
Hearing Loss | 1 | 2022 | 784 | 0.110 |
Why?
|
Atrophy | 1 | 2019 | 1635 | 0.110 |
Why?
|
Psychometrics | 1 | 2024 | 3062 | 0.110 |
Why?
|
Paranasal Sinus Diseases | 1 | 2015 | 121 | 0.110 |
Why?
|
Cadaver | 2 | 2016 | 1359 | 0.110 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 167 | 0.110 |
Why?
|
Tomography, Optical Coherence | 1 | 2007 | 2932 | 0.110 |
Why?
|
Skin Aging | 1 | 2015 | 140 | 0.110 |
Why?
|
Retinal Artery Occlusion | 1 | 2014 | 82 | 0.110 |
Why?
|
Retrobulbar Hemorrhage | 1 | 2013 | 10 | 0.110 |
Why?
|
Rupture, Spontaneous | 1 | 2014 | 359 | 0.110 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2014 | 170 | 0.110 |
Why?
|
Disease Progression | 3 | 2019 | 13632 | 0.110 |
Why?
|
Maxillary Sinus | 1 | 2015 | 172 | 0.110 |
Why?
|
Calciphylaxis | 1 | 2015 | 130 | 0.110 |
Why?
|
Fever | 1 | 2021 | 1603 | 0.110 |
Why?
|
Bleomycin | 1 | 2014 | 491 | 0.110 |
Why?
|
Antifungal Agents | 2 | 2015 | 769 | 0.110 |
Why?
|
Arachnoid | 1 | 2013 | 50 | 0.110 |
Why?
|
Child | 5 | 2024 | 80564 | 0.110 |
Why?
|
Ear | 1 | 2014 | 172 | 0.110 |
Why?
|
Melanocytes | 1 | 2016 | 515 | 0.100 |
Why?
|
Elastin | 1 | 2014 | 299 | 0.100 |
Why?
|
Optic Nerve Glioma | 1 | 2013 | 32 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2017 | 1831 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1426 | 0.100 |
Why?
|
Pneumocephalus | 1 | 2013 | 46 | 0.100 |
Why?
|
Cartilage | 1 | 2016 | 798 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2021 | 1393 | 0.100 |
Why?
|
Amyloidosis | 1 | 2020 | 885 | 0.100 |
Why?
|
Dermis | 1 | 2014 | 204 | 0.100 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 729 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2226 | 0.100 |
Why?
|
Antigens, CD20 | 1 | 2012 | 198 | 0.090 |
Why?
|
Goblet Cells | 1 | 2015 | 301 | 0.090 |
Why?
|
Acute Disease | 1 | 2022 | 7232 | 0.090 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2015 | 445 | 0.090 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15880 | 0.090 |
Why?
|
Hemangioma | 1 | 2016 | 723 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2023 | 2041 | 0.090 |
Why?
|
Infant | 3 | 2023 | 36386 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 679 | 0.090 |
Why?
|
Panniculitis, Lupus Erythematosus | 1 | 2010 | 4 | 0.090 |
Why?
|
Horns | 1 | 2009 | 9 | 0.090 |
Why?
|
Vision, Binocular | 1 | 2011 | 225 | 0.080 |
Why?
|
Radiotherapy | 1 | 2016 | 1494 | 0.080 |
Why?
|
Occipital Lobe | 1 | 2011 | 376 | 0.080 |
Why?
|
Photic Stimulation | 1 | 2016 | 1993 | 0.080 |
Why?
|
Cicatrix | 1 | 2015 | 798 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2018 | 6203 | 0.080 |
Why?
|
Platelet Count | 1 | 2012 | 782 | 0.080 |
Why?
|
Osteotomy | 1 | 2015 | 833 | 0.080 |
Why?
|
Optic Nerve | 1 | 2013 | 567 | 0.080 |
Why?
|
Demyelinating Diseases | 1 | 2011 | 355 | 0.080 |
Why?
|
Suture Techniques | 1 | 2014 | 773 | 0.080 |
Why?
|
Transplantation, Autologous | 1 | 2014 | 2120 | 0.080 |
Why?
|
Eye Movements | 1 | 2011 | 510 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2012 | 1602 | 0.070 |
Why?
|
Chronic Disease | 2 | 2013 | 9347 | 0.070 |
Why?
|
Ocular Motility Disorders | 1 | 2009 | 144 | 0.070 |
Why?
|
Stem Cells | 1 | 2021 | 3540 | 0.070 |
Why?
|
Reference Values | 1 | 2015 | 4908 | 0.070 |
Why?
|
Actins | 1 | 2015 | 2056 | 0.070 |
Why?
|
Facial Paralysis | 1 | 2011 | 346 | 0.070 |
Why?
|
Visual Pathways | 1 | 2011 | 555 | 0.070 |
Why?
|
Neuroglia | 1 | 2013 | 964 | 0.070 |
Why?
|
Sheep | 1 | 2009 | 1440 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9373 | 0.070 |
Why?
|
Corpus Callosum | 1 | 2011 | 751 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4893 | 0.060 |
Why?
|
Intubation | 2 | 2020 | 141 | 0.060 |
Why?
|
Meningioma | 1 | 2014 | 1221 | 0.060 |
Why?
|
Meningeal Neoplasms | 1 | 2014 | 1252 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8733 | 0.060 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1434 | 0.060 |
Why?
|
Diagnostic Imaging | 2 | 2016 | 3529 | 0.060 |
Why?
|
Equipment Design | 1 | 2013 | 3481 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10383 | 0.060 |
Why?
|
Vitreous Hemorrhage | 1 | 2005 | 47 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 3733 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5891 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2024 | 65188 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2011 | 1714 | 0.050 |
Why?
|
Quality Improvement | 1 | 2019 | 3853 | 0.050 |
Why?
|
Lichen Planus | 1 | 2024 | 71 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2012 | 1587 | 0.050 |
Why?
|
Optic Disk | 1 | 2007 | 421 | 0.050 |
Why?
|
Hospitalization | 1 | 2023 | 10808 | 0.050 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 2022 | 38 | 0.050 |
Why?
|
Bone Marrow | 1 | 2012 | 2921 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2975 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2024 | 326 | 0.050 |
Why?
|
Intracranial Aneurysm | 1 | 2011 | 1272 | 0.050 |
Why?
|
Eye Evisceration | 1 | 2021 | 21 | 0.050 |
Why?
|
Vitrectomy | 1 | 2005 | 389 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8703 | 0.050 |
Why?
|
Eye Enucleation | 1 | 2021 | 128 | 0.050 |
Why?
|
Brain Injuries | 1 | 2013 | 2060 | 0.050 |
Why?
|
Crohn Disease | 1 | 2012 | 2283 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26318 | 0.040 |
Why?
|
Prospective Studies | 3 | 2022 | 54802 | 0.040 |
Why?
|
Edema | 1 | 2022 | 760 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 281 | 0.040 |
Why?
|
Melanoma | 1 | 2015 | 5719 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1105 | 0.030 |
Why?
|
Rhizopus | 1 | 2015 | 22 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10850 | 0.030 |
Why?
|
Nasal Cavity | 1 | 2016 | 307 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1966 | 0.030 |
Why?
|
Sclerotherapy | 1 | 2014 | 184 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2113 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 2015 | 376 | 0.030 |
Why?
|
Risk Factors | 3 | 2015 | 74840 | 0.020 |
Why?
|
Blood Sedimentation | 1 | 2012 | 233 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40065 | 0.020 |
Why?
|
Mycoses | 1 | 2014 | 389 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1102 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1617 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2260 | 0.020 |
Why?
|
Nasal Mucosa | 1 | 2012 | 416 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4025 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1565 | 0.020 |
Why?
|
Shaken Baby Syndrome | 1 | 2005 | 24 | 0.010 |
Why?
|
Graft Survival | 1 | 2015 | 3890 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2792 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2074 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6919 | 0.010 |
Why?
|
Colonoscopy | 1 | 2012 | 1406 | 0.010 |
Why?
|
Birth Injuries | 1 | 2005 | 150 | 0.010 |
Why?
|
Health Surveys | 1 | 2013 | 4056 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2015 | 3425 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4209 | 0.010 |
Why?
|
Animals | 4 | 2016 | 168764 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18380 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4034 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2016 | 26346 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4270 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9649 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1171 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 30260 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 22223 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21480 | 0.010 |
Why?
|
Child, Preschool | 1 | 2010 | 42500 | 0.000 |
Why?
|